Illumina's Stock Climbs 29 Percent on Strong Q2 Revenue Growth, Profit | GenomeWeb

NEW YORK (GenomeWeb News) - Shares in Illumina were up more than 29 percent, or $8.42, at $37.28 in mid-afternoon trading after the company reported strong second-quarter earnings.
 
As GenomeWeb News reported this morning, Illumina reported a 163-percent surge in second-quarter revenues and swung into profitability from a loss in the second quarter of 2005.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.